Tumor-associated eosinophilotactic factor.
D000707:Anaphylaxis; D002277:Carcinoma / Q000097:blood / Q000150:complications / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D002633:Chemotaxis; D002850:Chromatography, Gel; D004802:Eosinophilia / Q000209:etiology; D004804:Eosinophils / Q000276:immunology*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D006969:Hypersensitivity, Immediate; D008168:Lung / Q000032:analysis / Q000473:pathology; D008175:Lung Neoplasms / Q000097:blood / Q000150:complications / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D008875:Middle Aged; D008970:Molecular Weight; D009369:Neoplasms / Q000276:immunology*; D010447:Peptide Hydrolases / Q000494:pharmacology; D010455:Peptides / Q000302:isolation & purification*
D010455:Peptides; D010447:Peptide Hydrolases